MRD-negative duration following latest line of therapy predicts long-term PFS in real-world patients with multiple myeloma.
作者信息
Chen Lucia Y, Thibaud Santiago, Bodnar Saoirse, Chari Ajai, Richter Joshua, Cho Hearn Jay, Sanchez Larysa J, Rodriguez Cesar, Rossi Adriana C, Richard Shambavi, Parekh Samir, Jagannath Sundar
机构信息
Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Oxford University, Oxford, United Kingdom.
Division of Hematology/Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
出版信息
Blood Adv. 2025 Jan 14;9(1):176-179. doi: 10.1182/bloodadvances.2024014097.
Abstract
摘要
Zotero 插件